Details
- Organisation Name: QIMR Berghofer Medical Research Institute
- HHS: N/A
- Services Offered: Early Phase, Pre-clinical, Bench research, Investigator Initiated Trials
- Website Address: www.qimrberghofer.edu.au
- Contact: [email protected]
- Other Affiliated Research Sites: N/A
Location
-27.4491356580931, 153.02725959838406
Initiating study activities approval
No
Review required
Greater than 2 weeks
Site Overview
QIMR Berghofer is a translational research institute where research develops from the laboratory bench through to the patient's bedside. The Institute was established in 1945 as a statutory body under the Queensland Institute of Medical Research Act 1945.
Since then, QIMR Berghofer has established itself as a world leader in scientific research while retaining its proud role as Queensland's own medical research institute. QIMR Berghofer focuses on the research areas of cancer, infectious diseases, mental health and chronic disorders. It also has a long-established Indigenous research program. The Institute's priority is to translate research from the laboratory bench to the hospital bedside and the broader community in order to improve human health. It does that by developing new and better prevention strategies, diagnostic tools and treatments. In conducting its research, the Institute supports different Queensland scientific and medical sectors, and promotes and develops links with industry.
QIMR Berghofer is home to approximately 1000 scientists, support staff and students. It is home to a TGA-approved facility for the manufacture of cellular immunotherapies. An early-phase clinical trial facility is also based on the premises.
Over its 75-year history, QIMR Berghofer has led global advances in understanding, preventing, diagnosing and treating some of the world's most deadly and debilitating diseases. The Institute is recognised as a world leader in research into the cutting-edge fields of immunotherapy and genomics. It also has an international reputation for its research into skin cancer, malaria and other mosquito-borne diseases, and the genetic risk factors associated with various cancers and mental health disorders.
Since then, QIMR Berghofer has established itself as a world leader in scientific research while retaining its proud role as Queensland's own medical research institute. QIMR Berghofer focuses on the research areas of cancer, infectious diseases, mental health and chronic disorders. It also has a long-established Indigenous research program. The Institute's priority is to translate research from the laboratory bench to the hospital bedside and the broader community in order to improve human health. It does that by developing new and better prevention strategies, diagnostic tools and treatments. In conducting its research, the Institute supports different Queensland scientific and medical sectors, and promotes and develops links with industry.
QIMR Berghofer is home to approximately 1000 scientists, support staff and students. It is home to a TGA-approved facility for the manufacture of cellular immunotherapies. An early-phase clinical trial facility is also based on the premises.
Over its 75-year history, QIMR Berghofer has led global advances in understanding, preventing, diagnosing and treating some of the world's most deadly and debilitating diseases. The Institute is recognised as a world leader in research into the cutting-edge fields of immunotherapy and genomics. It also has an international reputation for its research into skin cancer, malaria and other mosquito-borne diseases, and the genetic risk factors associated with various cancers and mental health disorders.
HREC
- HREC Committee Name: QIMR Berghofer Human Research Ethics Committee
- Meeting frequency: Other
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Local
- Mandate distribution of safety: Yes
- Meeting frequency: Other
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Local
- Mandate distribution of safety: Yes
Facility staffing and training
- Handling Investigational Product: Yes
- Training program for the research staff: Yes
- Include GCP: Yes
- Facility written sop during transportation to satellite site: N/A
- Training program for the research staff: Yes
- Include GCP: Yes
- Facility written sop during transportation to satellite site: N/A
Licenses to receive, store, dispense and return controlled substances
- Required Licenses or Registrations: Yes
- Does the Facility have the ability to handle radio-labelled Investigational Products? No
- Does the Facility have the ability to handle radio-labelled Investigational Products? No
Equipment
- Investigational Product: Vertical laminar flow hood (chemo/hazardous drugs)
- Centrifuge: Yes
- Refrigerated Centrifuge: Yes
- Centrifuge: Yes
- Refrigerated Centrifuge: Yes
Patient Records
- Record Archiving: Yes
- EMR/EHR systems: In-house
- Has your Clinical Trial Site or Service been accredited? Not Applicable
- Audit Type: Not Applicable
- EMR/EHR systems: In-house
- Has your Clinical Trial Site or Service been accredited? Not Applicable
- Audit Type: Not Applicable
Investigational product storage Capabilities
- Refrigerator (2 to 8 Degrees C): Yes
- Freezer (-20 to -30 Degrees C): Yes
- Investigational Freezer (-70 to -80 Degrees C): Yes
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): Yes
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
- Freezer (-20 to -30 Degrees C): Yes
- Investigational Freezer (-70 to -80 Degrees C): Yes
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): Yes
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
Specialty Research Area
Cardiovascular Diseases
Digestive System Diseases
Immune System Diseases
Mental Disorders
Neoplasms
Virus Diseases
Study Types
Academic
Industry
Investigator
Source Document Types
Paper and Electronic
Average time to start study (in calendar days)
30-60
How long prior to HREC meeting does the application need to be submitted?
Greater than 2 weeks
Does the HREC committee require contract /budget approval prior to release final approval documents?
Yes
Support in-patient admissions
No
PK & PD specimens
Yes
Study Phase Capability
Phase I
Type of Diagnostic Equipment
NA Not Applicable
Patient Population
Paediatrics
Adolescents/Adults 16 and onwards
Adults 18 and onwards
Geriatrics 65 and onwards